Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

MIRMMirum Pharmaceuticals, Inc.

Nasdaq · CIK 0001759425
Filer categoryLarge accelerated filer
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts284

Identity from submissions API

NameMirum Pharmaceuticals, Inc.
CIK0001759425
TickersMIRM
ExchangesNasdaq
Entity typeoperating
CategoryLarge accelerated filer
SIC2834 Pharmaceutical Preparations
EIN831281555
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone650-667-4085
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • None listed.
Business address
989 EAST HILLSDALE BOULEVARD, SUITE 300
FOSTER CITY
CA
94404
CA
Mailing address
989 EAST HILLSDALE BOULEVARD, SUITE 300
FOSTER CITY
CA
94404
CA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

681 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-20 144 xsl144X01/primary_doc.xml 0001950047-26-011400 001-38981 261579779 33 6340
2026-11-17 4 xslF345X06/form4-11172026_101145.xml 0001547959-26-000019 8548
2026-11-16 144 xsl144X01/primary_doc.xml 0001950047-26-011118 001-38981 261560405 33 4750
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001274173-26-000242 005-91075 261558213 34 13073
2026-11-13 4 xslF345X06/form4-11132026_091146.xml 0001365619-26-000007 10643
2026-11-12 144 xsl144X01/primary_doc.xml 0001950047-26-011005 001-38981 261543651 33 4939
2026-11-10 8-K 8-K 8.01 0001759425-26-000064 001-38981 261537991 34 171797 1 1
2026-11-04 4 xslF345X06/form4-11052026_011100.xml 0001614740-26-000015 9358
2026-11-04 144 xsl144X01/primary_doc.xml 0001670138-26-000007 001-38981 261524309 33 4724
2026-11-04 144 xsl144X01/primary_doc.xml 0001950047-26-010687 001-38981 261522782 33 6339
2026-11-03 10-Q 10-Q 0001759425-26-000062 001-38981 261517371 34 10320109 1 1
2026-11-03 8-K 8-K 2.02,9.01 0001759425-26-000061 001-38981 261517260 34 1607179 1 1
2026-10-26 8-K 8-K 8.01 0001759425-26-000054 001-38981 261486459 34 157840 1 1
2026-10-19 4 xslF345X06/form4-10192026_041001.xml 0001974200-26-000014 6985
2026-10-14 4 xslF345X06/form4-10142026_081046.xml 0002155916-26-000004 8300
2026-10-13 8-K 8-K 8.01 0001759425-26-000051 001-38981 261454742 34 181767 1 1
2026-10-06 4 xslF345X06/form4-10072026_121019.xml 0001614740-26-000014 11298
2026-09-28 8-K 8-K 8.01 0001759425-26-000049 001-38981 261412012 34 194669 1 1
2026-09-22 3 xslF345X06/form3-09232026_010947.xml 0002155916-26-000003 9728
2026-09-15 144 xsl144X01/primary_doc.xml 0001197350-26-000011 001-38981 261381021 33 6095
2026-09-15 4 xslF345X06/form4-09152026_040901.xml 0001197350-26-000010 8868
2026-09-08 8-K 8-K 5.02 0001759425-26-000047 001-38981 261363493 34 143760 1 1
2026-09-03 4 xslF345X06/form4-09032026_100913.xml 0001974200-26-000013 4964
2026-09-03 4 xslF345X06/form4-09032026_100954.xml 0001614740-26-000013 11868
2026-09-02 144 xsl144X01/primary_doc.xml 0001950047-26-008986 001-38981 261354769 33 7690
2026-09-01 144 xsl144X01/primary_doc.xml 0001950047-26-008900 001-38981 261351007 33 6339
2026-08-19 4 xslF345X06/form4-08192026_100826.xml 0001974200-26-000012 8450
2026-08-18 144 xsl144X01/primary_doc.xml 0001950047-26-008352 001-38981 261292053 33 6874
2026-08-13 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001274173-26-000210 005-91075 261271760 34 13037
2026-08-12 4 xslF345X06/form4-08122026_090835.xml 0001197350-26-000009 5533
2026-08-11 4 xslF345X06/form4-08112026_090838.xml 0001614740-26-000012 13539
2026-08-11 144 xsl144X01/primary_doc.xml 0001950047-26-007935 001-38981 261263316 33 6678
2026-08-10 144 xsl144X01/primary_doc.xml 0001950047-26-007862 001-38981 261258674 33 6339
2026-08-06 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000315066-26-002080 005-91075 261247157 34 11545
2026-08-05 4 xslF345X06/form4-08052026_080847.xml 0001974200-26-000011 4970
2026-08-05 10-Q 10-Q 0001759425-26-000045 001-38981 261243430 34 9786362 1 1
2026-08-05 8-K 8-K 2.02,9.01 0001759425-26-000044 001-38981 261243245 34 1595210 1 1
2026-08-03 144 xsl144X01/primary_doc.xml 0001950047-26-007486 001-38981 261232891 33 6840
2026-07-08 4 xslF345X06/form4-07082026_090744.xml 0001614740-26-000011 15446
2026-07-08 4 xslF345X06/form4-07082026_090727.xml 0001197350-26-000008 10610
2026-07-06 144 xsl144X01/primary_doc.xml 0001950047-26-006855 001-38981 261155972 33 5619
2026-07-06 144 xsl144X01/primary_doc.xml 0001950047-26-006854 001-38981 261155959 33 5471
2026-07-02 4 xslF345X06/form4-07022026_100751.xml 0001974200-26-000010 4967
2026-07-01 144 xsl144X01/primary_doc.xml 0001950047-26-006797 001-38981 261146619 33 5536
2026-06-18 4 xslF345X06/form4-06182026_100638.xml 0001974200-26-000009 4968
2026-06-18 8-K 8-K 5.07 0001193125-26-275811 001-38981 261102515 34 150003 1 1
2026-06-17 4 xslF345X06/form4-06172026_080620.xml 0001349376-26-000004 15067
2026-06-17 4 xslF345X06/form4-06172026_080618.xml 0001854337-26-000004 15108
2026-06-17 4 xslF345X06/form4-06172026_080616.xml 0001547959-26-000016 15071
2026-06-17 4 xslF345X06/form4-06172026_080609.xml 0001727275-26-000004 15374
2026-06-17 4 xslF345X06/form4-06172026_080608.xml 0001365619-26-000005 15303
2026-06-17 4 xslF345X06/form4-06172026_080605.xml 0001365617-26-000004 15281
2026-06-17 4 xslF345X06/form4-06172026_080603.xml 0001379344-26-000005 8245
2026-06-17 4 xslF345X06/form4-06172026_080601.xml 0001240122-26-000005 15094
2026-06-17 144 xsl144X01/primary_doc.xml 0001950047-26-006244 001-38981 261098239 33 5991
2026-06-09 4 xslF345X06/form4-06102026_010600.xml 0001197350-26-000007 12991
2026-06-08 4 xslF345X06/form4-06082026_080628.xml 0001650131-26-000011 6977
2026-06-08 144 xsl144X01/primary_doc.xml 0001950047-26-005748 001-38981 261072914 33 5471
2026-06-02 4 xslF345X06/form4-06022026_070609.xml 0001614740-26-000010 19217
2026-06-02 4 xslF345X06/form4-06022026_070607.xml 0001349376-26-000002 7177
2026-06-02 4 xslF345X06/form4-06022026_070605.xml 0001854337-26-000002 7227
2026-06-02 4 xslF345X06/form4-06022026_070603.xml 0001547959-26-000011 8828
2026-06-02 4 xslF345X06/form4-06022026_070601.xml 0001379344-26-000003 7222
2026-06-01 144 xsl144X01/primary_doc.xml 0001950047-26-005448 001-38981 261052534 33 5619
2026-06-01 144 xsl144X01/primary_doc.xml 0001950047-26-005336 001-38981 261050633 33 6906
2026-05-18 4 xslF345X06/form4-05192026_120532.xml 0001547959-26-000009 8547
2026-05-18 8-K 8-K 1.01,2.03,3.02,8.01,9.01 0001193125-26-228902 001-38981 26993156 34 997439 1 1
2026-05-15 144 xsl144X01/primary_doc.xml 0001950047-26-004580 001-38981 26987246 33 6183
2026-05-06 10-Q 10-Q 0001759425-26-000037 001-38981 26948345 34 8675652 1 1
2026-05-06 8-K 8-K 2.02,9.01 0001759425-26-000036 001-38981 26948226 34 1578553 1 1
2026-05-04 8-K 8-K 8.01 0001193125-26-202609 001-38981 26934680 34 166661 1 1
2026-04-27 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0002012383-26-001752 005-91075 26901121 34 11169
2026-04-27 8-K 8-K 8.01 0001193125-26-179048 001-38981 26896639 34 167556 1 1
2026-04-24 ARS ARS 0001140361-26-016603 001-38981 26890934 34 1121814
2026-04-23 DEFA14A DEFA14A 0001759425-26-000028 001-38981 26889290 34 522030
2026-04-23 DEF 14A DEF 14A 0001759425-26-000027 001-38981 26889246 34 13236129 1 1
2026-04-16 4 xslF345X06/form4-04172026_120419.xml 0001547959-26-000007 8548
2026-04-15 144 xsl144X01/primary_doc.xml 0001950047-26-003474 001-38981 26864268 33 6183
2026-04-08 8-K/A 8-K/A 9.01 0001759425-26-000021 001-38981 26848275 34 831499 1 1
2026-03-27 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000102909-26-001893 005-91075 26802469 34 7174
2026-03-17 4 xslF345X05/form4-03172026_070311.xml 0001197350-26-000006 14439
2026-03-17 4 xslF345X05/form4-03172026_070309.xml 0001670138-26-000005 14487
2026-03-17 4 xslF345X05/form4-03172026_070313.xml 0001547959-26-000006 8412
2026-03-17 4 xslF345X05/form4-03172026_070307.xml 0001650131-26-000010 18238
2026-03-17 4 xslF345X05/form4-03172026_070304.xml 0001974200-26-000008 18221
2026-03-17 4 xslF345X05/form4-03172026_070301.xml 0001614740-26-000009 18964
2026-03-17 144 xsl144X01/primary_doc.xml 0001197350-26-000005 001-38981 26764150 33 12011
2026-03-17 144 xsl144X01/primary_doc.xml 0001670138-26-000004 001-38981 26764139 33 12049
2026-03-17 144 xsl144X01/primary_doc.xml 0001650131-26-000009 001-38981 26764126 33 12934
2026-03-17 144 xsl144X01/primary_doc.xml 0001974200-26-000007 001-38981 26764106 33 12904
2026-03-17 144 xsl144X01/primary_doc.xml 0001614740-26-000008 001-38981 26764094 33 13049
2026-03-16 144 xsl144X01/primary_doc.xml 0001950047-26-002614 001-38981 26756632 33 7617
2026-03-11 4 xslF345X05/form4-03112026_080315.xml 0001650131-26-000008 6836
2026-02-25 S-3ASR S-3ASR 0001193125-26-072098 333-293762 26680166 33 542787 1 1
2026-02-25 S-8 S-8 0001759425-26-000015 333-293748 26679338 33 236638 1 1
2026-02-25 10-K 10-K 0001759425-26-000013 001-38981 26679118 34 11405133 1 1
2026-02-25 8-K 8-K 2.02,9.01 0001759425-26-000010 001-38981 26678377 34 1589539 1 1
2026-02-17 4 xslF345X05/form4-02172026_090212.xml 0001547959-26-000005 8413
2026-02-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001274173-26-000084 005-91075 26642368 34 12076
2026-02-13 144 xsl144X01/primary_doc.xml 0001950047-26-001236 001-38981 26632523 33 6900
2026-02-13 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001580642-26-001063 005-91075 26630815 34 11728
2026-02-03 4 xslF345X05/form4-02032026_090206.xml 0001650131-26-000007 4826
2026-02-03 4 xslF345X05/form4-02032026_090204.xml 0001614740-26-000007 5541
2026-02-03 4 xslF345X05/form4-02032026_090202.xml 0001974200-26-000006 8891
2026-02-02 144 xsl144X01/primary_doc.xml 0001974200-26-000005 001-38981 26589835 33 6289
2026-02-02 144 xsl144X01/primary_doc.xml 0001650131-26-000006 001-38981 26589822 33 6306
2026-02-02 144 xsl144X01/primary_doc.xml 0001614740-26-000006 001-38981 26589809 33 6415
2026-01-30 4 xslF345X05/form4-01302026_060108.xml 0001974200-26-000004 10673
2026-01-30 4 xslF345X05/form4-01302026_060106.xml 0001670138-26-000003 10680
2026-01-30 4 xslF345X05/form4-01302026_060105.xml 0001197350-26-000004 10626
2026-01-30 4 xslF345X05/form4-01302026_060103.xml 0001650131-26-000005 10682
2026-01-30 4 xslF345X05/form4-01302026_060101.xml 0001614740-26-000005 10693
2026-01-29 D xslFormDX01/primary_doc.xml 06c 0001759425-26-000005 021-571698 26578053 33 14492
2026-01-28 144 xsl144X01/primary_doc.xml 0001974200-26-000003 001-38981 26574028 33 5527
2026-01-28 144 xsl144X01/primary_doc.xml 0001197350-26-000003 001-38981 26574023 33 5479
2026-01-28 144 xsl144X01/primary_doc.xml 0001650131-26-000004 001-38981 26574021 33 5541
2026-01-28 144 xsl144X01/primary_doc.xml 0001614740-26-000004 001-38981 26574016 33 5647
2026-01-27 4 xslF345X05/form4-01272026_040108.xml 0001197350-26-000002 8882
2026-01-27 4 xslF345X05/form4-01272026_040106.xml 0001650131-26-000003 8896
2026-01-27 4 xslF345X05/form4-01272026_040105.xml 0001974200-26-000002 8893
2026-01-27 4 xslF345X05/form4-01272026_040103.xml 0001614740-26-000003 9571
2026-01-27 4 xslF345X05/form4-01272026_090122.xml 0001365617-26-000002 8845
2026-01-27 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001231919-26-000093 005-91075 26565646 34 93593
2026-01-26 8-K 8-K 2.01,7.01,8.01,9.01 0001193125-26-022582 001-38981 26560602 34 175459 1 1
2026-01-23 4 xslF345X05/form4-01232026_050110.xml 0001974200-26-000001 8894
2026-01-23 4 xslF345X05/form4-01232026_050108.xml 0001670138-26-000002 8937
2026-01-23 4 xslF345X05/form4-01232026_050106.xml 0001197350-26-000001 9118
2026-01-23 4 xslF345X05/form4-01232026_050104.xml 0001650131-26-000002 9132
2026-01-23 4 xslF345X05/form4-01232026_050101.xml 0001614740-26-000002 9572
2026-01-21 4 xslF345X05/form4-01212026_040103.xml 0001670138-26-000001 9088
2026-01-16 4 xslF345X05/form4-01162026_090102.xml 0001547959-26-000002 8412
2026-01-15 144 xsl144X01/primary_doc.xml 0001950047-26-000431 001-38981 26536236 33 6183
2026-01-12 8-K 8-K 2.02,7.01,9.01 0001759425-26-000004 001-38981 26524848 34 9117375 1 1
2026-01-02 4 xslF345X05/form4-01022026_090131.xml 0001614740-26-000001 5536
2025-12-23 4 xslF345X05/form4-12232025_111209.xml 0001547959-25-000008 8408
2025-12-23 4 xslF345X05/form4-12232025_111200.xml 0001240122-25-000011 9892
2025-12-22 144 xsl144X01/primary_doc.xml 0001950047-25-010594 001-38981 251592417 33 5467
2025-12-19 4 xslF345X05/form4-12192025_091243.xml 0001547959-25-000007 9917
2025-12-19 8-K 8-K 8.01 0001193125-25-326822 001-38981 251587563 34 137260 1 1
2025-12-19 144 xsl144X01/primary_doc.xml 0001950047-25-010541 001-38981 251587541 33 6224
2025-12-19 8-K 8-K 1.01,3.02,7.01,9.01 0001193125-25-325825 001-38981 251585136 34 488009 1 1
2025-12-18 144 xsl144X01/primary_doc.xml 0001950047-25-010493 001-38981 251583165 33 4750
2025-12-08 8-K 8-K 1.01,3.02,7.01,8.01,9.01 0001193125-25-310611 001-38981 251554680 34 5724231 1 1
2025-12-05 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001274173-25-000321 005-91075 251552108 34 9573
2025-12-02 4 xslF345X05/form4-12022025_091224.xml 0001240122-25-000007 9895
2025-12-01 144 xsl144X01/primary_doc.xml 0001950047-25-009503 001-38981 251539686 33 5509
2025-11-25 4 xslF345X05/form4-11252025_041104.xml 0001240122-25-000006 9895
2025-11-21 144 xsl144X01/primary_doc.xml 0001950047-25-009188 001-38981 251508021 33 4794
2025-11-20 4 xslF345X05/form4-11202025_091110.xml 0001614740-25-000005 7800
2025-11-17 8-K 8-K 8.01 0001759425-25-000057 001-38981 251491656 34 143262 1 1
2025-11-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000921895-25-003107 005-91075 251486366 34 23208
2025-11-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001274173-25-000293 005-91075 251483223 34 9572
2025-11-04 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001231919-25-000420 005-91075 251450855 34 46203
2025-11-04 10-Q 10-Q 0001759425-25-000054 001-38981 251448904 34 8320793 1 1
2025-11-04 8-K 8-K 2.02,9.01 0001759425-25-000053 001-38981 251448827 34 1584238 1 1
2025-09-12 4 xslF345X05/form4-09122025_080904.xml 0001415889-25-024463 10500
2025-09-12 4 xslF345X05/form4-09122025_080902.xml 0001415889-25-024462 8735
2025-09-11 144 xsl144X01/primary_doc.xml 0001950047-25-006973 001-38981 251308533 33 4695
2025-09-10 4 xslF345X05/form4-09102025_090933.xml 0001415889-25-024128 8575
2025-09-09 S-8 S-8 0001759425-25-000045 333-290137 251303825 33 402163 1 1
2025-09-08 144 xsl144X01/primary_doc.xml 0001950047-25-006827 001-38981 251300094 33 4657
2025-08-20 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001415889-25-022494 005-91075 251237744 34 38131
2025-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001274173-25-000218 005-91075 251215752 34 9573
2025-08-12 4 xslF345X05/form4-08122025_110857.xml 0001415889-25-021522 9063
2025-08-12 4 xslF345X05/form4-08122025_110854.xml 0001415889-25-021521 9224
2025-08-12 S-3ASR S-3ASR 0001193125-25-178937 333-289525 251206639 33 1437496 1 1
2025-08-11 144 xsl144X01/primary_doc.xml 0001950047-25-005599 001-38981 251202009 33 5705
2025-08-08 4 xslF345X05/form4-08082025_080836.xml 0001415889-25-021351 8498
2025-08-08 4 xslF345X05/form4-08082025_080828.xml 0001415889-25-021350 9617
2025-08-07 144 xsl144X01/primary_doc.xml 0001950047-25-005530 001-38981 251194540 33 6372
2025-08-07 144 xsl144X01/primary_doc.xml 0001950047-25-005528 001-38981 251194520 33 4939
2025-08-06 10-Q 10-Q 0001759425-25-000041 001-38981 251189518 34 7887334 1 1
2025-08-06 8-K 8-K 2.02,9.01 0001759425-25-000040 001-38981 251189420 34 270199 1 1
2025-07-03 4 xslF345X05/form4-07032025_100743.xml 0001415889-25-019378 10396
2025-07-03 144 xsl144X01/primary_doc.xml 0001950047-25-004832 001-38981 251104723 33 5609
2025-06-13 4 xslF345X05/form4-06132025_080649.xml 0001415889-25-017188 4596
2025-06-11 144 xsl144X01/primary_doc.xml 0001950047-25-004131 001-38981 251039937 33 4739
2025-06-06 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001274173-25-000183 005-91075 251029573 34 9573
2025-06-04 4 xslF345X05/form4-06042025_080640.xml 0001415889-25-015570 9619
2025-06-03 144 xsl144X01/primary_doc.xml 0001950047-25-003778 001-38981 251020683 33 5459
2025-06-02 4 xslF345X05/form4-06022025_110625.xml 0001415889-25-015306 11836
2025-06-02 4 xslF345X05/form4-06022025_110622.xml 0001415889-25-015305 14441
2025-06-02 4 xslF345X05/form4-06022025_110615.xml 0001415889-25-015304 8102
2025-06-02 4 xslF345X05/form4-06022025_110641.xml 0001415889-25-015303 12092
2025-06-02 4 xslF345X05/form4-06022025_110622.xml 0001415889-25-015302 12089
2025-06-02 4 xslF345X05/form4-06022025_110626.xml 0001415889-25-015301 11886
2025-06-02 4 xslF345X05/form4-06022025_110600.xml 0001415889-25-015300 7890
2025-06-02 4 xslF345X05/form4-06022025_110638.xml 0001415889-25-015299 11842
2025-06-02 144 xsl144X01/primary_doc.xml 0001950047-25-003721 001-38981 251016576 33 4699
2025-05-30 8-K 8-K 5.07 0001759425-25-000034 001-38981 251011595 34 152304 1 1
2025-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001274173-25-000178 005-91075 25951989 34 9570
2025-05-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001274173-25-000128 005-91075 25943806 34 10671
2025-05-07 10-Q 10-Q 0001759425-25-000032 001-38981 25921374 34 7353653 1 1
2025-05-07 8-K 8-K 2.02,9.01 0001759425-25-000030 001-38981 25921132 34 262359 1 1
2025-05-07 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001274173-25-000112 005-91075 25919905 34 9571
2025-04-14 ARS ARS 0001140361-25-013762 001-38981 25836219 34 1121633
2025-04-14 DEFA14A DEFA14A 0001759425-25-000024 001-38981 25836099 34 274008
2025-04-14 DEF 14A DEF 14A 0001759425-25-000022 001-38981 25836077 34 10014745 1 1
2025-03-19 4 xslF345X05/form4-03192025_090306.xml 0001415889-25-008608 5226
2025-03-18 4 xslF345X05/form4-03182025_090306.xml 0001415889-25-008558 18261
2025-03-18 4 xslF345X05/form4-03182025_090304.xml 0001415889-25-008557 8765
2025-03-18 4 xslF345X05/form4-03182025_090301.xml 0001415889-25-008556 9473
2025-03-18 4 xslF345X05/form4-03182025_090327.xml 0001415889-25-008439 8616
2025-03-18 144 xsl144X01/primary_doc.xml 0001950047-25-001997 001-38981 25748427 33 10968
2025-03-17 144 xsl144X01/primary_doc.xml 0001950047-25-001926 001-38981 25744780 33 8904
2025-03-12 4 xslF345X05/form4-03122025_080317.xml 0001415889-25-007828 10407
2025-03-10 4 xslF345X05/form4-03102025_090354.xml 0001415889-25-007540 8616
2025-03-06 4 xslF345X05/form4-03062025_100339.xml 0001415889-25-007260 10164
2025-03-05 4 xslF345X05/form4-03052025_090314.xml 0001415889-25-006955 6521
2025-03-04 144 xsl144X01/primary_doc.xml 0001972362-25-000219 001-38981 25705518 33 9336
2025-03-04 4 xslF345X05/form4-03042025_090312.xml 0001415889-25-006524 11516
2025-03-03 144 xsl144X01/primary_doc.xml 0001950047-25-001456 001-38981 25698859 33 7237
2025-02-26 S-8 S-8 0001759425-25-000016 333-285272 25670321 33 248023 1 1
2025-02-26 10-K 10-K 0001759425-25-000014 001-38981 25670079 34 11558856 1 1
2025-02-26 8-K 8-K 2.02,9.01 0001759425-25-000012 001-38981 25669975 34 286215 1 1
2025-02-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001274173-25-000068 005-91075 25625519 34 9582
2025-02-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001274173-25-000062 005-91075 25625497 34 10751
2025-02-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001580642-25-001012 005-91075 25625464 34 14889
2025-02-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001580642-25-001010 005-91075 25625378 34 13869
2025-02-04 4 xslF345X05/form4-02042025_050206.xml 0001415889-25-002982 4840
2025-02-04 4 xslF345X05/form4-02042025_050204.xml 0001415889-25-002981 5545
2025-02-04 4 xslF345X05/form4-02042025_050201.xml 0001415889-25-002980 8893
2025-01-27 4 xslF345X05/form4-01272025_090133.xml 0001415889-25-002137 8913
2025-01-27 4 xslF345X05/form4-01272025_090146.xml 0001415889-25-002136 7195
2025-01-27 4 xslF345X05/form4-01272025_090147.xml 0001415889-25-002135 8887
2025-01-27 4 xslF345X05/form4-01272025_090100.xml 0001415889-25-002134 9577
2025-01-23 4 xslF345X05/form4-01232025_100106.xml 0001415889-25-001955 10679
2025-01-23 4 xslF345X05/form4-01232025_100156.xml 0001415889-25-001954 8100
2025-01-23 4 xslF345X05/form4-01232025_100126.xml 0001415889-25-001953 8097
2025-01-23 4 xslF345X05/form4-01232025_100138.xml 0001415889-25-001952 10701
2025-01-23 4 xslF345X05/form4-01232025_100149.xml 0001415889-25-001951 10687
2025-01-21 4 xslF345X05/form4-01212025_090130.xml 0001415889-25-001779 8807
2025-01-13 8-K 8-K 2.02,7.01,9.01 0001759425-25-000003 001-38981 25524977 34 6706659 1 1
2025-01-08 4 xslF345X05/form4-01082025_090118.xml 0001415889-25-001144 4840
2025-01-08 4 xslF345X05/form4-01082025_090146.xml 0001415889-25-001143 5545
2025-01-08 4 xslF345X05/form4-01082025_090147.xml 0001415889-25-001142 8832
2024-11-15 4 xslF345X05/form4-11152024_101149.xml 0001415889-24-026974 8501
2024-11-14 SC 13G/A AMENDMENT NO. 1 TO SCHEDULE 13G 0000921895-24-002733 005-91075 241463473 34 276880
2024-11-14 4 xslF345X05/form4-11142024_091104.xml 0001415889-24-026873 4850
2024-11-14 4 xslF345X05/form4-11142024_091128.xml 0001415889-24-026870 4849
2024-11-14 4 xslF345X05/form4-11142024_091113.xml 0001415889-24-026868 5616
2024-11-14 SC 13G/A JANUS AMENDMENT 0001274173-24-000125 005-91075 241459621 34 10525
2024-11-14 SC 13G/A SC 13G/A 0001580642-24-006956 005-91075 241459364 34 56825
2024-11-12 SC 13G/A us6047491013_111224.txt 0002012383-24-004377 005-91075 241445738 34 13906
2024-11-12 10-Q 10-Q 0001759425-24-000038 001-38981 241443634 34 7888048 1 1
2024-11-12 8-K 8-K 2.02,9.01 0001759425-24-000037 001-38981 241443536 34 282705 1 1
2024-10-22 SC 13G/A us6047491013_102224.txt 0002012383-24-001602 005-91075 241387327 34 13893
2024-10-01 4 xslF345X05/form4-10012024_081000.xml 0001415889-24-024195 5589
2024-09-20 4 xslF345X05/form4-09202024_080957.xml 0001415889-24-023777 6448
2024-09-12 4 xslF345X05/form4-09122024_080946.xml 0001415889-24-023289 7091
2024-09-10 4 xslF345X05/form4-09102024_090910.xml 0001415889-24-023154 6999
2024-08-07 10-Q 10-Q 0001759425-24-000031 001-38981 241183863 34 8111583 1 1
2024-08-07 8-K 8-K 2.02,9.01 0001759425-24-000029 001-38981 241183611 34 281877 1 1
2024-07-24 4 xslF345X05/form4-07242024_090744.xml 0001415889-24-020053 7717
2024-07-10 SC 13G JANUS HENDERSON OWNS 10 0001274173-24-000073 005-91075 241109435 34 10526
2024-07-03 4 xslF345X05/form4-07032024_100734.xml 0001415889-24-019276 8743
2024-07-01 144 xsl144X01/primary_doc.xml 0001950047-24-005183 001-38981 241092040 33 4857
2024-06-25 4 xslF345X05/form4-06252024_090650.xml 0001415889-24-018159 9174
2024-06-24 144 xsl144X01/primary_doc.xml 0001950047-24-004995 001-38981 241064810 33 4842
2024-06-17 8-K 8-K 8.01 0001193125-24-162056 001-38981 241046995 34 152248 1 1
2024-06-07 4 xslF345X05/form4-06072024_100632.xml 0001415889-24-016071 8113
2024-06-07 4 xslF345X05/form4-06072024_100631.xml 0001415889-24-016070 7857
2024-06-07 4 xslF345X05/form4-06072024_100643.xml 0001415889-24-016069 7901
2024-06-07 4 xslF345X05/form4-06072024_100651.xml 0001415889-24-016068 7890
2024-06-07 4 xslF345X05/form4-06072024_100603.xml 0001415889-24-016066 7849
2024-06-07 4 xslF345X05/form4-06072024_100617.xml 0001415889-24-016065 8118
2024-06-07 4 xslF345X05/form4-06072024_100615.xml 0001415889-24-016064 12914
2024-06-07 4 xslF345X05/form4-06072024_100607.xml 0001415889-24-016063 7887
2024-06-06 8-K 8-K 5.07 0001759425-24-000023 001-38981 241026047 34 166009 1 1
2024-05-31 8-K 8-K 8.01 0001193125-24-151965 001-38981 241010851 34 151034 1 1
2024-05-16 4 xslF345X05/form4-05162024_040533.xml 0001415889-24-013356 4812
2024-05-16 4 xslF345X05/form4-05162024_040530.xml 0001415889-24-013355 5580
2024-05-16 4 xslF345X05/form4-05162024_040526.xml 0001415889-24-013354 5563
2024-05-08 10-Q 10-Q 0001759425-24-000019 001-38981 24926320 34 6973629 1 1
2024-05-08 8-K 8-K 2.02,9.01 0001759425-24-000017 001-38981 24925796 34 255251 1 1
2024-04-23 ARS ARS 0001140361-24-021367 001-38981 24865221 34 1753035
2024-04-23 DEFA14A DEFA14A 0001759425-24-000012 001-38981 24865095 34 458936
2024-04-23 DEF 14A DEF 14A 0001759425-24-000011 001-38981 24865085 34 1363831
2024-03-27 4 xslF345X05/form4-03282024_120312.xml 0001415889-24-009280 4558
2024-03-25 4 xslF345X05/form4-03252024_090335.xml 0001415889-24-009046 5011
2024-03-18 4 xslF345X05/form4-03182024_090306.xml 0001415889-24-008322 4807
2024-03-18 4 xslF345X05/form4-03182024_090327.xml 0001415889-24-008320 5496
2024-03-18 4 xslF345X05/form4-03182024_090300.xml 0001415889-24-008316 6661
2024-03-18 4 xslF345X05/form4-03182024_090320.xml 0001415889-24-008313 5836
2024-03-18 4 xslF345X05/form4-03182024_090313.xml 0001415889-24-008311 4558
2024-03-15 S-8 S-8 0001193125-24-069301 333-278011 24756164 33 81416
2024-03-15 10-K 10-K 0000950170-24-032289 001-38981 24755770 34 15921226 1 1
2024-02-28 NT 10-K NT 10-K 0001193125-24-050798 001-38981 24696573 34 26767
2024-02-28 8-K 8-K 2.02,9.01 0001759425-24-000005 001-38981 24695204 34 287700 1 1
2024-02-14 SC 13G/A SC 13G/A 0001580642-24-000990 005-91075 24635167 34 56078
2024-02-13 SC 13G SCHEDULE 13G 0001104659-24-021478 005-91075 24628987 34 13014
2024-02-05 4 xslF345X05/form4-02062024_020209.xml 0001415889-24-002757 5497
2024-02-05 4 xslF345X05/form4-02062024_020236.xml 0001415889-24-002756 4795
2024-02-05 4 xslF345X05/form4-02062024_020222.xml 0001415889-24-002755 4808
2024-02-05 4 xslF345X05/form4-02062024_020203.xml 0001415889-24-002754 5513
2024-02-02 4 xslF345X05/form4-02032024_020214.xml 0001415889-24-002412 8863
2024-01-31 SC 13G us6047491013_013124.txt 0001086364-24-006067 005-91075 24582187 34 13544
2024-01-25 4 xslF345X05/form4-01252024_070108.xml 0001415889-24-001826 8103
2024-01-25 4 xslF345X05/form4-01252024_070106.xml 0001415889-24-001825 8108
2024-01-25 4 xslF345X05/form4-01252024_070104.xml 0001415889-24-001824 8057
2024-01-25 4 xslF345X05/form4-01252024_070108.xml 0001415889-24-001827 8105
2024-01-25 4 xslF345X05/form4-01252024_070101.xml 0001415889-24-001823 8124
2024-01-25 4 xslF345X05/form4-01252024_070102.xml 0001415889-24-001822 8128
2024-01-18 4 xslF345X05/form4-01192024_120106.xml 0001415889-24-001561 8095
2024-01-18 3 xslF345X02/form3-01192024_120107.xml 0001415889-24-001560 8202
2024-01-16 8-K 8-K 5.02 0001193125-24-008569 001-38981 24535332 34 145227 1 1
2024-01-09 4 xslF345X05/form4-01102024_010106.xml 0001415889-24-000884 4814
2024-01-09 4 xslF345X05/form4-01102024_010122.xml 0001415889-24-000883 4796
2024-01-09 4 xslF345X05/form4-01102024_010110.xml 0001415889-24-000882 5507
2024-01-09 4 xslF345X05/form4-01102024_010133.xml 0001415889-24-000881 5507
2024-01-09 4 xslF345X05/form4-01102024_010137.xml 0001415889-24-000880 8845
2024-01-08 8-K 8-K 2.02,7.01,9.01 0001193125-24-003965 001-38981 24518493 34 4822996 1 1
2023-12-29 SC 13D/A NEW ENTERPRISE ASSOCIATES 16, L.P. / MIRUM PHARMACEUTICALS, INC. -- SCHEDULE 13D 0001072613-23-000635 005-91075 231527597 34 100711
2023-12-18 8-K 8-K 8.01 0001193125-23-297614 001-38981 231493749 34 147334 1 1
2023-12-06 4 FORM 4 SUBMISSION 0001209191-23-057650 8562
2023-11-15 4 FORM 4 SUBMISSION 0001209191-23-055436 5553
2023-11-15 4 FORM 4 SUBMISSION 0001209191-23-055434 4842
2023-11-15 4 FORM 4 SUBMISSION 0001209191-23-055433 4860
2023-11-14 4 FORM 4 SUBMISSION 0001209191-23-055180 6475
2023-11-02 S-8 S-8 0001193125-23-269483 333-275283 231373434 33 78433
2023-11-02 424B5 424B5 0001193125-23-269478 333-267357 231373388 33 621166
2023-11-02 10-Q 10-Q 0000950170-23-058228 001-38981 231372514 34 14304213 1 1
2023-11-02 8-K MIRUM PHARMACEUTICALS, INC. 8-K 2.02,9.01 0001157523-23-001631 001-38981 231372232 34 378700 1 1
2023-11-02 8-K/A 8-K/A 9.01 0001193125-23-269359 001-38981 231372193 34 718303 1 1
2023-10-17 8-K 8-K 8.01 0001193125-23-257711 001-38981 231330004 34 152244 1 1
2023-10-13 S-3ASR S-3ASR 0001193125-23-256146 333-274973 231325505 33 294041
2023-10-13 8-K 8-K 8.01,9.01 0001193125-23-256103 001-38981 231325248 34 759210 1 1
2023-09-18 SC 13G SCHEDULE 13G 0000921895-23-002186 005-91075 231261588 34 285775
2023-09-15 4 FORM 4 SUBMISSION 0001209191-23-049614 7023
2023-09-14 4 FORM 4 SUBMISSION 0001209191-23-049511 15436
2023-09-14 144 xsl144X01/primary_doc.xml 0001950047-23-004048 001-38981 231255775 33 5378
2023-09-13 4 FORM 4 SUBMISSION 0001209191-23-049292 8992
2023-09-12 4 FORM 4 SUBMISSION 0001209191-23-049133 10093
2023-09-12 3 FORM 3 SUBMISSION 0001209191-23-049129 6035
2023-09-11 8-K 8-K 5.02,9.01 0001193125-23-232481 001-38981 231247952 34 191947 1 1
2023-09-06 144 xsl144X01/primary_doc.xml 0001972362-23-000779 001-38981 231240215 33 4152
2023-09-05 SC 13D/A SC 13D/A 0001193125-23-228444 005-91075 231235353 34 544877
2023-09-05 4 FORM 4 SUBMISSION 0001209191-23-048086 6477
2023-09-05 8-K 8-K 2.01,3.02,7.01,9.01 0001193125-23-228131 001-38981 231234227 34 200058 1 1
2023-08-30 8-K 8-K 5.02,9.01 0001193125-23-224944 001-38981 231225435 34 311513 1 1
2023-08-28 4 FORM 4 SUBMISSION 0001209191-23-047515 4555
2023-08-07 10-Q 10-Q 0000950170-23-038716 001-38981 231145521 34 14228368 1 1
2023-08-03 8-K MIRUM PHARMACEUTICALS, INC. 8-K 2.02,9.01 0001157523-23-001254 001-38981 231139865 34 321290 1 1
2023-07-17 8-K 8-K 1.01,3.02,7.01,9.01 0001193125-23-187712 001-38981 231090578 34 2964901 1 1
2023-07-05 4 FORM 4 SUBMISSION 0001209191-23-041344 4786
2023-07-05 4 FORM 4 SUBMISSION 0001209191-23-041338 4768
2023-07-05 4 FORM 4 SUBMISSION 0001209191-23-041337 5480
2023-07-05 4 FORM 4 SUBMISSION 0001209191-23-041333 12909
2023-07-05 4 FORM 4 SUBMISSION 0001209191-23-041330 5480
2023-06-23 SC 13D/A NEW ENTERPRISE ASSOCIATES 16, L.P. / MIRUM PHARMACEUTICALS, INC. -- SCHEDULE 13D 0001072613-23-000370 005-91075 231037047 34 384291
2023-06-15 4 FORM 4 SUBMISSION 0001209191-23-037366 12136
2023-06-15 4 FORM 4 SUBMISSION 0001209191-23-037363 19501
2023-06-15 4 FORM 4 SUBMISSION 0001209191-23-037361 14752
2023-06-15 4 FORM 4 SUBMISSION 0001209191-23-037360 14119
2023-06-15 4 FORM 4 SUBMISSION 0001209191-23-037356 11421
2023-06-15 4 FORM 4 SUBMISSION 0001209191-23-037353 12091
2023-06-15 4 FORM 4 SUBMISSION 0001209191-23-037346 11998
2023-06-15 4 FORM 4 SUBMISSION 0001209191-23-037343 11642
2023-06-15 4 FORM 4 SUBMISSION 0001209191-23-037333 6001
2023-06-14 4 FORM 4 SUBMISSION 0001209191-23-037135 5358
2023-06-14 4 FORM 4 SUBMISSION 0001209191-23-037133 8463
2023-06-14 4 FORM 4 SUBMISSION 0001209191-23-037131 8444
2023-06-14 4 FORM 4 SUBMISSION 0001209191-23-037129 8454
2023-06-14 4 FORM 4 SUBMISSION 0001209191-23-037127 8445
2023-06-14 4 FORM 4 SUBMISSION 0001209191-23-037124 8476
2023-06-14 4 FORM 4 SUBMISSION 0001209191-23-037123 8414
2023-06-14 4 FORM 4 SUBMISSION 0001209191-23-037122 5373
2023-06-13 8-K 8-K 5.07 0001193125-23-166018 001-38981 231011252 34 156531 1 1
2023-06-09 4 FORM 4 SUBMISSION 0001209191-23-035831 10188
2023-06-08 144 xsl144X01/primary_doc.xml 0001950047-23-001435 001-38981 231003115 33 5290
2023-05-19 4 FORM 4 SUBMISSION 0001209191-23-030964 7936
2023-05-19 4 FORM 4 SUBMISSION 0001209191-23-030966 7917
2023-05-19 4 FORM 4 SUBMISSION 0001209191-23-030962 8624
2023-05-19 4 FORM 4 SUBMISSION 0001209191-23-030951 8623
2023-05-09 3 FORM 3 SUBMISSION 0001209191-23-028316 20876
2023-05-04 4 FORM 4 SUBMISSION 0001209191-23-027549 13265
2023-05-04 10-Q 10-Q 0000950170-23-017879 001-38981 23888975 34 11780845 1 1
2023-05-04 8-K MIRUM PHARMACEUTICALS, INC. 8-K 2.02,9.01 0001157523-23-000741 001-38981 23888522 34 275762 1 1
2023-05-03 144 xsl144X01/primary_doc.xml 0001950047-23-000374 001-38981 23885556 33 4640
2023-05-03 SC 13G/A e618579_sc13ga-mirum.htm 0001193805-23-000657 005-91075 23885136 34 130158
2023-05-01 ARS ARS 0001140361-23-022060 001-38981 23873926 34 1742296
2023-05-01 DEFA14A DEFA14A 0001140361-23-022058 001-38981 23873900 34 4002396
2023-05-01 DEF 14A DEF14A 0001140361-23-022054 001-38981 23873873 34 2080481
2023-04-17 8-K 8-K 1.01,1.02,2.03,3.02,9.01 0001193125-23-103622 001-38981 23824174 34 957428 1 1
2023-04-14 SC 13D/A SC 13D/A 0001193125-23-101762 005-91075 23820428 34 431283
2023-04-12 8-K 8-K 2.02,8.01,9.01 0001193125-23-098423 001-38981 23814597 34 184404 1 1
2023-04-06 4 FORM 4 SUBMISSION 0001209191-23-023648 5350
2023-04-06 3 FORM 3 SUBMISSION 0001209191-23-023645 6009
2023-04-06 8-K 8-K 5.02 0001193125-23-093126 001-38981 23804385 34 152677 1 1
2023-03-10 8-K 8-K 8.01 0001193125-23-067794 001-38981 23724986 34 154343 1 1
2023-03-09 S-8 S-8 0001193125-23-066124 333-270399 23719975 33 89187
2023-03-08 10-K 10-K 0000950170-23-006715 001-38981 23716322 34 15899834 1 1
2023-03-08 8-K MIRUM PHARMACEUTICALS, INC. 8-K 2.02,9.01 0001157523-23-000411 001-38981 23716116 34 306369 1 1
2023-03-08 SC 13G/A us6047491013_030723.txt 0001306550-23-008791 005-91075 23715590 34 12374
2023-02-14 SC 13G/A rocksprings-mirm123122a4.htm 0001172661-23-001259 005-91075 23627621 34 109798
2023-02-14 SC 13G SC 13G 0001580642-23-000863 005-91075 23626527 34 58493
2023-02-10 SC 13G/A e618234_sc13ga-mirum.htm 0001193805-23-000121 005-91075 23608909 34 131453
2023-02-03 SC 13G us6047491013_020323.txt 0001306550-23-007707 005-91075 23586200 34 13307
2023-02-02 4 FORM 4 SUBMISSION 0001209191-23-006312 7241
2023-02-02 4 FORM 4 SUBMISSION 0001209191-23-006305 7952

Latest XBRL company facts

One latest value per concept from companyfacts (284 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 65.28M 2026-10-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
dei EntityPublicFloat Entity Public Float USD 2.30B 2025-06-30 2025 FY 10-K 2026-02-25 0001759425-26-000013
ecd CoSelectedMeasureAmt CoSelectedMeasureAmt USD 521.31M 2025-01-01 2025-12-31 DEF 14A 2026-04-23 0001759425-26-000027
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 9.61M 2025-01-01 2025-12-31 DEF 14A 2026-04-23 0001759425-26-000027
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 3.49M 2025-01-01 2025-12-31 DEF 14A 2026-04-23 0001759425-26-000027
ecd PeerGroupTotalShareholderRtnAmt PeerGroupTotalShareholderRtnAmt USD 124.72 2025-01-01 2025-12-31 DEF 14A 2026-04-23 0001759425-26-000027
ecd PeoActuallyPaidCompAmt PeoActuallyPaidCompAmt USD 29.65M 2025-01-01 2025-12-31 DEF 14A 2026-04-23 0001759425-26-000027
ecd PeoTotalCompAmt PeoTotalCompAmt USD 10.44M 2025-01-01 2025-12-31 DEF 14A 2026-04-23 0001759425-26-000027
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 495.24 2025-01-01 2025-12-31 DEF 14A 2026-04-23 0001759425-26-000027
us-gaap AccountsAndOtherReceivablesNetCurrent Accounts and Other Receivables, Net, Current USD 400,000 2021-09-30 2021 Q3 10-Q 2021-11-15 0000950170-21-004605
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 13.65M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 156.35M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap AccretionAmortizationOfDiscountsAndPremiumsInvestments Accretion (Amortization) of Discounts and Premiums, Investments USD 1.73M 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-15 0000950170-24-032289
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 196.19M 2025-12-31 2025 FY 10-K 2026-02-25 0001759425-26-000013
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 23.73M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap AccruedRoyaltiesCurrent Accrued Royalties, Current USD 20.18M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 1.10M 2025-12-31 2025 FY 10-K 2026-02-25 0001759425-26-000013
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -2.06M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 1.51B 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 33.20M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap AdvertisingExpense Advertising Expense USD 10.90M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-25 0001759425-26-000013
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 121.36M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap AllowanceForDoubtfulAccountsReceivable Accounts Receivable, Allowance for Credit Loss USD 0 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap AmortizationOfFinancingCostsAndDiscounts Amortization of Debt Issuance Costs and Discounts USD 1.96M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap AmortizationOfIntangibleAssets Amortization of Intangible Assets USD 20.30M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 18.11M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap AreaOfLand Area of Land sqft 5,600 2019-01-31 2024 FY 10-K 2025-02-26 0001759425-25-000014
us-gaap AssetAcquisitionContingentConsiderationLiabilityCurrent AssetAcquisitionContingentConsiderationLiabilityCurrent USD 24.80M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap AssetAcquisitionContingentConsiderationLiabilityNoncurrent AssetAcquisitionContingentConsiderationLiabilityNoncurrent USD 44.65M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap Assets Assets USD 1.03B 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap AssetsCurrent Assets, Current USD 586.63M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap AssetsFairValueDisclosure Assets, Fair Value Disclosure USD 426.74M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax USD 0 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax USD 1.71M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 428.44M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Fair Value USD 149.59M 2022-09-30 2022 Q3 10-Q 2022-11-09 0000950170-22-023519
us-gaap AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Remainder of Fiscal Year USD 140.49M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value USD 267.25M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One USD 86.64M 2025-12-31 2025 FY 10-K 2026-02-25 0001759425-26-000013
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 426.74M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap AvailableForSaleSecuritiesDebtSecuritiesCurrent Debt Securities, Available-for-sale, Current USD 130.50M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap AvailableForSaleSecuritiesDebtSecuritiesNoncurrent Debt Securities, Available-for-sale, Noncurrent USD 126.77M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap AvailableForSaleSecuritiesGrossRealizedGainLossNet Available-for-sale Securities, Gross Realized Gain (Loss) USD 0 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-15 0000950170-21-004605
us-gaap AvailableForSaleSecuritiesGrossRealizedLosses Available-for-sale Securities, Gross Realized Losses USD 0 2019-01-01 2019-06-30 2019 Q2 10-Q 2019-08-28 0001564590-19-033345
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 42,000 2020-01-01 2020-06-30 2021 Q2 10-Q 2021-08-05 0000950170-21-000954
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 243.19M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap CashAndCashEquivalentsFairValueDisclosure Cash and Cash Equivalents, Fair Value Disclosure USD 169.47M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 244.92M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD -53.24M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap CommitmentsAndContingencies Commitments and Contingencies USD 0 2021-03-31 2021 Q1 10-Q 2021-05-06 0001564590-21-024994
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 27.16M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 200.00M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 65.21M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 65.21M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap CommonStockValue Common Stock, Value, Issued USD 7,000 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -900.55M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap ContractWithCustomerAssetNet Contract with Customer, Asset, after Allowance for Credit Loss USD 0 2026-03-31 2026 Q1 10-Q 2026-05-06 0001759425-26-000037
us-gaap ContractWithCustomerLiability Contract with Customer, Liability USD 5.90M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod Contract with Customer, Performance Obligation Satisfied in Previous Period USD 11.00M 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-06 0001759425-25-000041
us-gaap ConversionOfStockAmountIssued1 Conversion of Stock, Amount Issued USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-09 0001564590-21-011756
us-gaap ConvertibleDebtFairValueDisclosures Convertible Debt, Fair Value Disclosures USD 782.43M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap ConvertibleLongTermNotesPayable Convertible Notes Payable, Noncurrent USD 731.25M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap ConvertibleNotesPayable Convertible Notes Payable USD 731.25M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap CurrentFederalTaxExpenseBenefit Current Federal Tax Expense (Benefit) USD -80,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-25 0001759425-26-000013
us-gaap CurrentForeignTaxExpenseBenefit Current Foreign Tax Expense (Benefit) USD 1.20M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-25 0001759425-26-000013
us-gaap CurrentIncomeTaxExpenseBenefit Current Income Tax Expense (Benefit) USD 1.94M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-25 0001759425-26-000013
us-gaap CurrentStateAndLocalTaxExpenseBenefit Current State and Local Tax Expense (Benefit) USD 819,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-25 0001759425-26-000013
us-gaap DebtConversionConvertedInstrumentAmount1 Debt Conversion, Converted Instrument, Amount USD 600.88M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap DebtSecuritiesAvailableForSaleAllowanceForCreditLoss Debt Securities, Available-for-sale, Allowance for Credit Loss USD 0 2024-09-30 2024 Q3 10-Q 2024-11-12 0001759425-24-000038
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer USD 0 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap DebtSecuritiesAvailableForSaleRealizedGainLoss Debt Securities, Available-for-sale, Realized Gain (Loss) USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap DeferredFederalIncomeTaxExpenseBenefit Deferred Federal Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-25 0001759425-26-000013
us-gaap DeferredIncomeTaxExpenseBenefit Deferred Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-25 0001759425-26-000013
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 1.63M 2025-12-31 2025 FY 10-K 2026-02-25 0001759425-26-000013
us-gaap DeferredStateAndLocalIncomeTaxExpenseBenefit Deferred State and Local Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-25 0001759425-26-000013
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 183.45M 2025-12-31 2025 FY 10-K 2026-02-25 0001759425-26-000013
us-gaap DeferredTaxAssetsInventory Deferred Tax Assets, Inventory USD 1.77M 2025-12-31 2025 FY 10-K 2026-02-25 0001759425-26-000013
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 0 2025-12-31 2025 FY 10-K 2026-02-25 0001759425-26-000013
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 45.30M 2025-12-31 2025 FY 10-K 2026-02-25 0001759425-26-000013
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 0 2019-12-31 2019 FY 10-K 2020-03-12 0001564590-20-010471
us-gaap DeferredTaxAssetsTaxCreditCarryforwards Deferred Tax Assets, Tax Credit Carryforwards USD 49.30M 2025-12-31 2025 FY 10-K 2026-02-25 0001759425-26-000013
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsResearch Deferred Tax Assets, Tax Credit Carryforwards, Research USD 48.78M 2025-12-31 2025 FY 10-K 2026-02-25 0001759425-26-000013
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 9.88M 2025-12-31 2025 FY 10-K 2026-02-25 0001759425-26-000013
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals USD 7.07M 2025-12-31 2025 FY 10-K 2026-02-25 0001759425-26-000013
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 181.82M 2025-12-31 2025 FY 10-K 2026-02-25 0001759425-26-000013
us-gaap DeferredTaxLiabilitiesLeasingArrangements Deferred Tax Liabilities, Leasing Arrangements USD 1.53M 2025-12-31 2025 FY 10-K 2026-02-25 0001759425-26-000013
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 20.70M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap DepreciationExpenseOnReclassifiedAssets Depreciation Expense on Reclassified Assets USD 300,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-25 0001759425-26-000013
us-gaap DerivativeLiabilities Derivative Liability USD 0 2023-12-31 2024 FY 10-K 2025-02-26 0001759425-25-000014
us-gaap DerivativeLiabilitiesCurrent Derivative Liability, Current USD 0 2024-12-31 2025 FY 10-K 2026-02-25 0001759425-26-000013
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -14.35 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -1.17 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-05 0000950170-22-007812
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -14.35 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure -0.09 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-25 0001759425-26-000013
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-25 0001759425-26-000013
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.55 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-25 0001759425-26-000013
us-gaap EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectAmount EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectAmount USD 527,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-25 0001759425-26-000013
us-gaap EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectPercent EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectPercent pure -0.025 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-25 0001759425-26-000013
us-gaap EffectiveIncomeTaxRateReconciliationGiltiPercent EffectiveIncomeTaxRateReconciliationGiltiPercent pure 0.017 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-15 0000950170-24-032289
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent pure -0.004 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-25 0001759425-26-000013
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure 0.241 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-25 0001759425-26-000013
us-gaap EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent pure -0.004 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-25 0001759425-26-000013
us-gaap EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings Effective Income Tax Rate Reconciliation, Repatriation of Foreign Earnings, Percent pure -0.005 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-25 0001759425-26-000013
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure -0.03 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-25 0001759425-26-000013
us-gaap EffectiveIncomeTaxRateReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Percent pure -0.147 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-25 0001759425-26-000013
us-gaap EffectiveIncomeTaxRateReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Percent pure -0.589 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-25 0001759425-26-000013
us-gaap EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD -2.66M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 40.53M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount Share-based Payment Arrangement, Amount Capitalized USD 700,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-25 0001759425-26-000013
us-gaap FairValueAssetsLevel1ToLevel2TransfersAmount Fair Value, Assets, Level 1 to Level 2 Transfers, Amount USD 0 2019-12-31 2019 FY 10-K 2020-03-12 0001564590-20-010471
us-gaap FairValueAssetsLevel2ToLevel1TransfersAmount Fair Value, Assets, Level 2 to Level 1 Transfers, Amount USD 0 2019-12-31 2019 FY 10-K 2020-03-12 0001564590-20-010471
us-gaap FairValueLiabilitiesLevel1ToLevel2TransfersAmount Fair Value, Liabilities, Level 1 to Level 2 Transfers, Amount USD 0 2019-12-31 2019 FY 10-K 2020-03-12 0001564590-20-010471
us-gaap FairValueLiabilitiesLevel2ToLevel1TransfersAmount Fair Value, Liabilities, Level 2 to Level 1 Transfers, Amount USD 0 2019-12-31 2019 FY 10-K 2020-03-12 0001564590-20-010471
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3 Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers Into Level 3 USD 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-12 0001564590-20-010471
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3 Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers out of Level 3 USD 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-12 0001564590-20-010471
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3 Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3 USD 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-12 0001564590-20-010471
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3 Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3 USD 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-12 0001564590-20-010471
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases, (Sales), Issuances, (Settlements) USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-15 0000950170-24-032289
us-gaap FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationIssues Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Issues USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-26 0001759425-25-000014
us-gaap FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis with Unobservable Inputs USD 1.26M 2020-12-31 2021 FY 10-K 2022-03-09 0000950170-22-003229
us-gaap FinancialLiabilitiesFairValueDisclosure Financial Liabilities Fair Value Disclosure USD 44.65M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap FiniteLivedIntangibleAssetsAccumulatedAmortization Finite-Lived Intangible Assets, Accumulated Amortization USD 80.94M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive Finite-Lived Intangible Asset, Expected Amortization, after Year Five USD 127.00M 2025-12-31 2025 FY 10-K 2026-02-25 0001759425-26-000013
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths Finite-Lived Intangible Asset, Expected Amortization, Year One USD 29.59M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year USD 7.40M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFive Finite-Lived Intangible Asset, Expected Amortization, Year Five USD 26.74M 2025-12-31 2025 FY 10-K 2026-02-25 0001759425-26-000013
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFour Finite-Lived Intangible Asset, Expected Amortization, Year Four USD 29.59M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearThree Finite-Lived Intangible Asset, Expected Amortization, Year Three USD 29.59M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo Finite-Lived Intangible Asset, Expected Amortization, Year Two USD 29.59M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap FiniteLivedIntangibleAssetsGross Finite-Lived Intangible Assets, Gross USD 356.59M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap FiniteLivedIntangibleAssetsNet Finite-Lived Intangible Assets, Net USD 275.65M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap ForeignCurrencyTransactionGainLossRealizedAfterTax ForeignCurrencyTransactionGainLossRealizedAfterTax USD 800,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap ForeignCurrencyTransactionGainLossUnrealized Foreign Currency Transaction Gain (Loss), Unrealized USD -1.82M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap ForeignCurrencyTransactionGainLossUnrealizedAfterTax ForeignCurrencyTransactionGainLossUnrealizedAfterTax USD 1.90M 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-04 0001759425-25-000054
us-gaap GainsLossesOnExtinguishmentOfDebt Gain (Loss) on Extinguishment of Debt USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-25 0001759425-26-000013
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 59.22M 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-09 0000950170-22-003229
us-gaap HeldToMaturitySecuritiesFairValue Debt Securities, Held-to-maturity, Fair Value USD 149.59M 2022-09-30 2022 Q3 10-Q 2022-11-09 0000950170-22-023519
us-gaap ImpairmentOfLongLivedAssetsToBeDisposedOf Impairment of Long-Lived Assets to be Disposed of USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-25 0001759425-26-000013
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD -24.88M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-25 0001759425-26-000013
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -895.45M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign Income (Loss) from Continuing Operations before Income Taxes, Foreign USD 3.45M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-25 0001759425-26-000013
us-gaap IncomeTaxesPaid Income Taxes Paid USD 125,000 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-15 0000950170-24-032289
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 3.28M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 2.70M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap IncomeTaxPaidFederalAfterRefundReceived IncomeTaxPaidFederalAfterRefundReceived USD 53,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-25 0001759425-26-000013
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 11.78M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-25 0001759425-26-000013
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -4.50M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-25 0001759425-26-000013
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD 83,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-25 0001759425-26-000013
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD -5.17M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-25 0001759425-26-000013
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD 641,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-25 0001759425-26-000013
us-gaap IncomeTaxReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Amount USD 3.16M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-25 0001759425-26-000013
us-gaap IncomeTaxReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Amount USD 12.63M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-25 0001759425-26-000013
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD 39.69M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap IncreaseDecreaseInInventories Increase (Decrease) in Inventories USD 2.41M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -1.72M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap IncreaseDecreaseInOtherOperatingAssets Increase (Decrease) in Other Operating Assets USD 10.09M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 12.02M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap IntangibleAssetsNetExcludingGoodwill Intangible Assets, Net (Excluding Goodwill) USD 275.65M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap InterestExpenseDebt Interest Expense, Debt USD 7.84M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap InterestExpenseDebtExcludingAmortization Interest Expense, Debt, Excluding Amortization USD 5.88M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap InterestExpenseInterestBearingLiabilityIncreaseDecrease InterestExpenseInterestBearingLiabilityIncreaseDecrease USD 0 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-15 0000950170-24-032289
us-gaap InterestExpenseNonoperating InterestExpenseNonoperating USD 7.84M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 7.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap InterestPayableCurrent Interest Payable, Current USD 984,000 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap InventoryFinishedGoods Inventory, Finished Goods, Gross USD 4.04M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap InventoryNet Inventory, Net USD 25.49M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap InventoryRawMaterialsAndSupplies Inventory, Raw Materials and Supplies, Gross USD 2.92M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap InventoryWorkInProcess Inventory, Work in Process, Gross USD 18.53M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 11.94M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap Investments Investments USD 0 2018-12-31 2019 FY 10-K 2020-03-12 0001564590-20-010471
us-gaap InvestmentsAndCash Investments and Cash USD 500.50M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap LesseeOperatingLeaseDiscountRate Lessee, Operating Lease, Discount Rate pure 0.08 2019-09-30 2019 Q3 10-Q 2019-11-06 0001564590-19-041030
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 14.56M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 21,000 2025-12-31 2025 FY 10-K 2026-02-25 0001759425-26-000013
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 3.42M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 351,000 2025-12-31 2025 FY 10-K 2026-02-25 0001759425-26-000013
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 2.71M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 2.92M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 2.86M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 823,000 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 2.25M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap Liabilities Liabilities USD 1.08B 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 1.03B 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap LiabilitiesCurrent Liabilities, Current USD 283.08M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap LongTermInvestments Long-term Investments USD 126.77M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap LossContingencyNewClaimsFiledNumber Loss Contingency, New Claims Filed, Number claim 4 2025-12-19 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap LossContingencyPendingClaimsNumber Loss Contingency, Pending Claims, Number claim 4 2026-04-16 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 427.17M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -200.43M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -277.33M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -898.15M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -898.15M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap NetIncomeLossAvailableToCommonStockholdersDiluted Net Income (Loss) Available to Common Stockholders, Diluted USD -898.15M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap NumberOfOperatingSegments Number of Operating Segments segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap OperatingExpenses Operating Expenses USD 1.41B 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -891.75M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap OperatingLeaseExpense Operating Lease, Expense USD 2.40M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 12.31M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 2.60M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 9.72M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap OperatingLeasePayments Operating Lease, Payments USD 2.40M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 11.36M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap OperatingLeaseRightOfUseAssetAmortizationExpense Operating Lease, Right-of-Use Asset, Amortization Expense USD 144,000 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-04 0000950170-23-017879
us-gaap OperatingLeaseVariableLeaseIncome Operating Lease, Variable Lease Income USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.075 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap OtherAccruedLiabilitiesNoncurrent Other Accrued Liabilities, Noncurrent USD 973,000 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 21.23M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent USD -1.85M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent USD -560,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent Other Comprehensive Income (Loss), before Tax, Portion Attributable to Parent USD -1.38M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 12.10M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap OtherNoncashIncomeExpense Other Noncash Income (Expense) USD 929,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD -7.80M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale Other-than-temporary Impairment Loss, Debt Securities, Available-for-sale USD 0 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-02 0000950170-23-058228
us-gaap PaymentOfFinancingAndStockIssuanceCosts Payment of Financing and Stock Issuance Costs USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-25 0001759425-26-000013
us-gaap PaymentsForProceedsFromInvestments Payments for (Proceeds from) Investments USD 65.00M 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-08 0000950170-23-006715
us-gaap PaymentsForTenantImprovements Payments for Tenant Improvements USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-09 0001564590-21-011756
us-gaap PaymentsOfDebtIssuanceCosts Payments of Debt Issuance Costs USD 17.95M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap PaymentsToAcquireBusinessesGross Payments to Acquire Businesses, Gross USD 2.60M 2022-05-01 2022-05-31 2023 Q1 10-Q 2023-05-04 0000950170-23-017879
us-gaap PaymentsToAcquireBusinessesNetOfCashAcquired Payments to Acquire Businesses, Net of Cash Acquired USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-25 0001759425-26-000013
us-gaap PaymentsToAcquireInProcessResearchAndDevelopment Payments to Acquire in Process Research and Development USD 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-12 0001564590-20-010471
us-gaap PaymentsToAcquireIntangibleAssets Payments to Acquire Intangible Assets USD 35.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap PaymentsToAcquireInvestments Payments to Acquire Investments USD 249.38M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 1.99M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap PreferredStockLiquidationPreferenceValue Preferred Stock, Liquidation Preference, Value USD 0 2022-12-31 2022 FY 10-K 2023-03-08 0000950170-23-006715
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 10.00M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 31.11M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap ProceedsFromConvertibleDebt Proceeds from Convertible Debt USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-25 0001759425-26-000013
us-gaap ProceedsFromDebtNetOfIssuanceCosts Proceeds from Debt, Net of Issuance Costs USD 672.05M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-26 0001759425-25-000014
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-25 0001759425-26-000013
us-gaap ProceedsFromIssuanceOfPreferredStockAndPreferenceStock Proceeds from Issuance of Preferred Stock and Preference Stock USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-09 0001564590-21-011756
us-gaap ProceedsFromIssuanceOfPrivatePlacement Proceeds from Issuance of Private Placement USD 259.95M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock Proceeds from Issuance of Redeemable Convertible Preferred Stock USD 60.00M 2019-04-12 2019 Q2 10-Q 2019-08-28 0001564590-19-033345
us-gaap ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised USD 31.26M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale USD 85.94M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap ProceedsFromRelatedPartyDebt Proceeds from Related Party Debt USD 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-12 0001564590-20-010471
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -898.15M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 3.25M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap ProvisionForDoubtfulAccounts Accounts Receivable, Credit Loss Expense (Reversal) USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap ReclassificationsOfTemporaryToPermanentEquity Reclassifications of Temporary to Permanent Equity USD 6.99M 2019-01-01 2019-12-31 2020 FY 10-K 2021-03-09 0001564590-21-011756
us-gaap RepaymentsOfConvertibleDebt Repayments of Convertible Debt USD 536.08M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 28.61M 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-06 0001564590-19-041030
us-gaap ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost Research and Development Expense (Excluding Acquired in Process Cost) USD 296.37M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap ResearchAndDevelopmentInProcess Research and Development in Process USD 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-12 0001564590-20-010471
us-gaap RestrictedCashAndCashEquivalents Restricted Cash and Cash Equivalents USD 1.74M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap RestrictedCashEquivalents Restricted Cash Equivalents USD 1.74M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -1.57B 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 521.85M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap Revenues Revenues USD 19.14M 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-09 0000950170-22-003229
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 4.47M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap SellingGeneralAndAdministrativeExpense Selling, General and Administrative Expense USD 266.66M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 100.08M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap ShareBasedGoodsAndNonemployeeServicesTransactionModificationOfTermsIncrementalCompensationCost Share-based Goods and Nonemployee Services Transaction, Modification of Terms, Incremental Compensation Cost USD 600,000 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-15 0000950170-21-004605
us-gaap ShortTermInvestments Short-term Investments USD 130.50M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap ShortTermLeaseCommitmentAmount Short-term Lease Commitment, Amount USD 400,000 2019-09-30 2019 Q3 10-Q 2019-11-06 0001564590-19-041030
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD -54.19M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 0.125 2019-07-01 2019-07-31 2020 FY 10-K 2021-03-09 0001564590-21-011756
us-gaap StockIssued1 Stock Issued USD 329.09M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities Stock Issued During Period, Shares, Conversion of Convertible Securities shares 31 2026-04-01 2026-06-30 2026 Q2 10-Q 2026-08-05 0001759425-26-000045
us-gaap StockIssuedDuringPeriodValueAcquisitions Stock Issued During Period, Value, Acquisitions USD 415.27M 2026-01-01 2026-03-31 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 3,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap StockIssuedDuringPeriodValueEmployeeStockPurchasePlan Stock Issued During Period, Value, Employee Stock Purchase Plan USD 10.13M 2026-01-01 2026-03-31 2026 Q2 10-Q 2026-08-05 0001759425-26-000045
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 329.09M 2026-04-01 2026-06-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 345,000 2021-07-01 2021-09-30 2022 Q3 10-Q 2022-11-09 0000950170-22-023519
us-gaap TenantImprovements Tenant Improvements USD 400,000 2019-06-30 2019 Q2 10-Q 2019-08-28 0001564590-19-033345
us-gaap TreasuryStockCommonShares Treasury Stock, Common, Shares shares 456,445 2019-06-30 2019 Q2 10-Q 2019-08-28 0001564590-19-033345
us-gaap UndistributedEarningsOfForeignSubsidiaries Undistributed Earnings of Foreign Subsidiaries USD 0 2025-12-31 2025 FY 10-K 2026-02-25 0001759425-26-000013
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 17.12M 2025-12-31 2025 FY 10-K 2026-02-25 0001759425-26-000013
us-gaap UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions USD 110,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-25 0001759425-26-000013
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued USD 0 2021-12-31 2021 FY 10-K 2022-03-09 0000950170-22-003229
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions USD 4.27M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-25 0001759425-26-000013
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions USD 337,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-25 0001759425-26-000013
us-gaap UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate Unrecognized Tax Benefits that Would Impact Effective Tax Rate USD 3.60M 2020-12-31 2020 FY 10-K 2021-03-09 0001564590-21-011756
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 14.40M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-25 0001759425-26-000013
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 62.61M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 31.30M 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-05 0000950170-22-007812
us-gaap WeightedAverageNumberOfSharesContingentlyIssuable Weighted Average Number of Shares, Contingently Issuable shares 493,185 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 62.61M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001759425-26-000062

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →